Kornitzer Capital Management Inc Halozyme Therapeutics, Inc. Transaction History

Kornitzer Capital Management Inc

$4.72 Billion
Q3 2025

A detailed history of Kornitzer Capital Management Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 113,499 shares of HALO stock, worth $7.95 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

113,499

Previous 126,798 10.49%

Holding current value

$7.95 Million

Previous $6.6 Million 26.2%

% of portfolio

0.18%

Previous 0.14%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 31, 2025	SELL	$52.92 - $78.28 $703,783 - $1.04 Million	-13,299 Reduced 10.49%	113,499 $8.32 Million
Q2 2025 Jul 31, 2025	SELL	$47.91 - $70.14 $3.78 Million - $5.53 Million	-78,851 Reduced 38.34%	126,798 $6.6 Million
Q1 2025 May 02, 2025	SELL	$47.74 - $65.16 $360,437 - $491,958	-7,550 Reduced 3.54%	205,649 $13.1 Million
Q4 2024 Jan 31, 2025	SELL	$42.57 - $61.09 $9.73 Million - $14 Million	-228,665 Reduced 51.75%	213,199 $10.2 Million
Q3 2024 Oct 31, 2024	SELL	$51.3 - $64.42 $4.15 Million - $5.21 Million	-80,870 Reduced 15.47%	441,864 $25.3 Million

Q2 2024 Aug 02, 2024	BUY	$37.81 - $52.4 $1.42 Million - $1.97 Million	37,500 Added 7.73%	522,734 $27.4 Million
Q1 2024 May 01, 2024	BUY	$33.68 - $41.95 $353,640 - $440,475	10,500 Added 2.21%	485,234 $19.7 Million
Q4 2023 Jan 31, 2024	BUY	$33.32 - $42.1 $773,357 - $977,141	23,210 Added 5.14%	474,734 $17.5 Million
Q3 2023 Oct 31, 2023	BUY	$36.46 - $44.03 $901,655 - $1.09 Million	24,730 Added 5.79%	451,524 $17.2 Million
Q2 2023 Aug 01, 2023	BUY	$30.28 - $38.74 $78,728 - $100,724	2,600 Added 0.61%	426,794 $15.4 Million
Q1 2023 May 09, 2023	BUY	$32.86 - $55.7 $3.91 Million - $6.62 Million	118,845 Added 38.92%	424,194 $16.2 Million
Q4 2022 Feb 02, 2023	SELL	$40.06 - $59.44 $5.71 Million - $8.47 Million	-142,565 Reduced 31.83%	305,349 $17.4 Million
Q3 2022 Nov 03, 2022	SELL	$38.53 - $51.78 $3,853 - $5,178	-100 Reduced 0.02%	447,914 $17.7 Million
Q2 2022 Aug 03, 2022	SELL	$37.35 - $48.3 $3.69 Million - $4.77 Million	-98,701 Reduced 18.05%	448,014 $19.7 Million
Q4 2021 Feb 01, 2022	BUY	$31.82 - $40.75 $2.6 Million - $3.33 Million	81,785 Added 17.59%	546,715 $22 Million
Q2 2021 Jul 30, 2021	BUY	$38.84 - $51.31 $2.07 Million - $2.73 Million	53,235 Added 12.93%	464,930 $21.1 Million
Q4 2020 Jan 29, 2021	SELL	$25.81 - $43.62 $1.31 Million - $2.21 Million	-50,605 Reduced 10.95%	411,695 $17.6 Million
Q3 2020 Oct 30, 2020	SELL	$25.74 - $29.63 $127,799 - $147,112	-4,965 Reduced 1.06%	462,300 $12.1 Million
Q2 2020 Aug 03, 2020	SELL	$16.25 - $26.81 $56,631 - $93,432	-3,485 Reduced 0.74%	467,265 $12.5 Million
Q1 2020 Apr 30, 2020	BUY	$13.9 - $21.83 $2.83 Million - $4.45 Million	203,855 Added 76.38%	470,750 $8.47 Million
Q4 2019 Jan 31, 2020	BUY	$14.93 - $19.53 $3.98 Million - $5.21 Million	266,895 New	266,895 $4.73 Million

Others Institutions Holding HALO

# of Institutions

666

Shares Held

128M

Call Options Held

626K

Put Options Held

455K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.75B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Account

Kornitzer Capital Management Inc Halozyme Therapeutics, Inc. Transaction History